Literature DB >> 10471318

Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.

S E Mirski1, J H Gerlach, S P Cole.   

Abstract

The alpha and beta isoforms of DNA topoisomerase II (topo II) are targets for several widely used chemotherapeutic agents, and resistance to some of these drugs may be associated with reduced nuclear localization of the alpha isoform. Human topo IIalpha contains a strong bipartite nuclear localization signal (NLS) sequence between amino acids 1454 and 1497 (alphaNLS(1454-1497)). In the present study, we show that human topo IIalpha tagged with green fluorescence protein is still detectable in the nucleus when alphaNLS(1454-1497) has been disrupted. Seven additional regions in topo IIalpha containing overlapping potential bipartite NLSs were evaluated for their nuclear targeting abilities using a beta-galactosidase reporter system. A moderately functional NLS was identified between amino acids 1259 and 1296. When human topo IIbeta was examined in a similar fashion, it was found to contain two strongly functional sequences betaNLS(1522-1548) and betaNLS(1538-1573) in the region of topo IIbeta comparable to the region in topo IIalpha that contains the strongly functional alphaNLS(1454-1497). The third, betaNLS(1294-1332), although weaker than the other two beta sequences, is significantly stronger than the analogous alphaNLS(1259-1296). Differences in the NLS sequences of human topo II isoforms may contribute to their differences in subnuclear localization. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471318     DOI: 10.1006/excr.1999.4587

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.

Authors:  Parvathi Ranganathan; Trinayan Kashyap; Xueyan Yu; Xiaomei Meng; Tzung-Huei Lai; Betina McNeil; Bhavana Bhatnagar; Sharon Shacham; Michael Kauffman; Adrienne M Dorrance; William Blum; Deepa Sampath; Yosef Landesman; Ramiro Garzon
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

2.  Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.

Authors:  Chia-Yun Jessica Sun; Silvana van Koningsbruggen; Steven W Long; Kirsten Straasheijm; Rinse Klooster; Takako I Jones; Michel Bellini; Lyne Levesque; William M Brieher; Silvère M van der Maarel; Peter L Jones
Journal:  J Mol Biol       Date:  2011-06-15       Impact factor: 5.469

Review 3.  Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα.

Authors:  Terry S Elton; Victor A Hernandez; Jessika Carvajal-Moreno; Xinyi Wang; Deborah Ipinmoroti; Jack C Yalowich
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

4.  NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction.

Authors:  Alex N Nguyen Ba; Anastassia Pogoutse; Nicholas Provart; Alan M Moses
Journal:  BMC Bioinformatics       Date:  2009-06-29       Impact factor: 3.169

5.  Centromere-associated topoisomerase activity in bloodstream form Trypanosoma brucei.

Authors:  Samson O Obado; Christopher Bot; Maria C Echeverry; Julio C Bayona; Vanina E Alvarez; Martin C Taylor; John M Kelly
Journal:  Nucleic Acids Res       Date:  2010-09-22       Impact factor: 16.971

6.  The impact of the human DNA topoisomerase II C-terminal domain on activity.

Authors:  Emma L Meczes; Kathryn L Gilroy; Katherine L West; Caroline A Austin
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

7.  Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.

Authors:  Toshiyuki Kozuki; Kenichi Chikamori; Marius D Surleac; Marius A Micluta; Andrei J Petrescu; Eric J Norris; Paul Elson; Gerald A Hoeltge; Dale R Grabowski; Andrew C G Porter; Ram N Ganapathi; Mahrukh K Ganapathi
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

8.  C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

Authors:  René M Linka; Andrew C G Porter; Arsen Volkov; Christian Mielke; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

9.  Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1.

Authors:  Jessica P Wyles; Zhongqin Wu; Shelagh E L Mirski; Susan P C Cole
Journal:  Nucleic Acids Res       Date:  2007-06-12       Impact factor: 16.971

10.  Nuclear dynamics of topoisomerase IIβ reflects its catalytic activity that is regulated by binding of RNA to the C-terminal domain.

Authors:  Akihisa Onoda; Osamu Hosoya; Kuniaki Sano; Kazuko Kiyama; Hiroshi Kimura; Shinji Kawano; Ryohei Furuta; Mary Miyaji; Ken Tsutsui; Kimiko M Tsutsui
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.